The combination of granulocyte‐monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?-Reference-Cited by-同舟云学术

The combination of granulocyte‐monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?

Published:2019-09-13 Issue:6 Volume:34 Page:680-685
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J Clin Apher

Author:

Rodríguez‐Lago Iago¹²^ORCID,Benítez José M.³⁴,Sempere Laura⁵,Sáez‐González Esteban⁶^ORCID,Barreiro‐de Acosta Manuel⁷,Zárate Jone O.⁸,Cabriada José L.¹²

Affiliation:

1. Gastroenterology DepartmentHospital de Galdakao Galdakao Spain

2. Biocruces Bizkaia Health Research Institute Barakaldo Vizcaya Spain

3. Gastroenterology DepartmentHospital Universitario Reina Sofía Córdoba Spain

4. IMIBIC Córdoba Spain

5. Gastroenterology DepartmentHospital General Universitario de Alicante Alicante Spain

6. Gastroenterology DepartmentHospital Universitari i Politècnic La Fe Valencia Spain

7. Gastroenterology DepartmentHospital Clínico Universitario de Santiago de Compostela Santiago de Compostela Spain

8. Gastroenterology DepartmentHospital Universitario de Basurto Bilbao Spain

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jca.21746

Reference20 articles.

1. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

2. Vedolizumab in IBD–Lessons From Real-world Experience; A Systematic Review and Pooled Analysis

3. Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease

4. Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn’s Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis

5. A Randomized, Double-Blind, Sham-Controlled Study of Granulocyte/Monocyte Apheresis for Active Ulcerative Colitis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital;Gastroenterología y Hepatología;2024-08

2. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital;Gastroenterología y Hepatología (English Edition);2024-08

3. Comparison of early versus late addition of granulocyte and monocyte adsorption for incomplete remission induction in ulcerative colitis;JGH Open;2024-07

4. Combination of granulocyte–monocyte apheresis and ustekinumab: Multicentre and retrospective study;Gastroenterología y Hepatología;2024-05

5. The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study;Therapeutic Apheresis and Dialysis;2024-01-02